Targeting a Common Pathway in Genetic Forms of Obesity
RARECast - A podcast by RARECast - Thursdays
Categories:
David Meeker, CEO of Rhythm, discusses genetic obesities, the company’s drug Imcivree, and his plans to expand the use of the drug beyond the initial approved indications.
